MiR-199a-5p is negatively associated with malignancies and regulates glycolysis and lactate production by targeting hexokinase 2 in liver cancer.
about
Insights into the Regulatory Role of Non-coding RNAs in Cancer MetabolismThe sweet trap in tumors: aerobic glycolysis and potential targets for therapyPoor prognosis of hexokinase 2 overexpression in solid tumors of digestive system: a meta-analysis.Role of apoptosis-related miRNAs in resveratrol-induced breast cancer cell death.Interleukin-22 promotes aerobic glycolysis associated with tumor progression via targeting hexokinase-2 in human colon cancer cellsMutual Regulation of MiR-199a-5p and HIF-1α Modulates the Warburg Effect in Hepatocellular Carcinoma.The miR-125a/HK2 axis regulates cancer cell energy metabolism reprogramming in hepatocellular carcinomaPrognostic Significance of the Metabolic Marker Hexokinase-2 in Various Solid Tumors: A Meta-Analysis.miR-199a-5p confers tumor-suppressive role in triple-negative breast cancer.Suppression of miR-199a maturation by HuR is crucial for hypoxia-induced glycolytic switch in hepatocellular carcinoma.Biomarker MicroRNAs for Diagnosis, Prognosis and Treatment of Hepatocellular Carcinoma: A Functional Survey and Comparison.Regulation of HK2 expression through alterations in CpG methylation of the HK2 promoter during progression of hepatocellular carcinoma.Disruption of the EZH2/miRNA/β-catenin signaling suppresses aerobic glycolysis in glioma.Taurine upregulated gene 1 functions as a master regulator to coordinate glycolysis and metastasis in hepatocellular carcinoma.MiR-199a-5p suppresses tumorigenesis by targeting clathrin heavy chain in hepatocellular carcinoma.MicroRNA-150 regulates glycolysis by targeting von Hippel-Lindau in glioma cells.MicroRNA-181b inhibits glycolysis in gastric cancer cells via targeting hexokinase 2 gene.MetastamiRs: A promising choice for antihepatocellular carcinoma nucleic acid drug development.The role of microRNAs in hepatocyte metabolism and hepatitis B virus replication.MicroRNA regulation and analytical methods in cancer cell metabolism.Differential association of STAT3 and HK-II expression in hepatitis B virus- and hepatitis C virus-related hepatocellular carcinoma.Serum microRNA-199a/b-3p as a predictive biomarker for treatment response in patients with hepatocellular carcinoma undergoing transarterial chemoembolization.Small Non-coding RNA Abundance in Adrenocortical Carcinoma: A Footprint of a Rare Cancer.miR-125a suppresses viability and glycolysis and induces apoptosis by targeting Hexokinase 2 in laryngeal squamous cell carcinomaRegulation of Glycolytic Metabolism by Autophagy in Liver Cancer Involves Selective Autophagic Degradation of HK2 (hexokinase 2).Downregulation of miR-199a/b-5p is associated with GCNT2 induction upon epithelial-mesenchymal transition in colon cancer.The Glycolytic Switch in Tumors: How Many Players Are Involved?The microRNA-182-PDK4 axis regulates lung tumorigenesis by modulating pyruvate dehydrogenase and lipogenesis.Mutant CTNNB1 and histological heterogeneity define metabolic subtypes of hepatoblastoma.Mitochondrial calcium uniporter as a target of microRNA-340 and promoter of metastasis via enhancing the Warburg effect.Serum Metabolic Profile Alteration Reveals Response to Platinum-Based Combination Chemotherapy for Lung Cancer: Sensitive Patients Distinguished from Insensitive ones.Non-coding RNAs in hepatocellular carcinoma: molecular functions and pathological implications.Norisoboldine, a natural AhR agonist, promotes Treg differentiation and attenuates colitis via targeting glycolysis and subsequent NAD+/SIRT1/SUV39H1/H3K9me3 signaling pathway.miR-139-5p inhibits aerobic glycolysis, cell proliferation, migration, and invasion in hepatocellular carcinoma via a reciprocal regulatory interaction with ETS1.MicroRNA‑34a inhibits liver cancer cell growth by reprogramming glucose metabolism.miR199a-5p inhibits hepatic insulin sensitivity via suppression of ATG14-mediated autophagy.In silico identification of microRNAs predicted to regulate N-myristoyltransferase and Methionine Aminopeptidase 2 functions in cancer and infectious diseases.MicroRNA-98 Suppress Warburg Effect by Targeting HK2 in Colon Cancer Cells.microRNA-129-5p, a c-Myc negative target, affects hepatocellular carcinoma progression by blocking the Warburg effect.Long noncoding RNA miR503HG, a prognostic indicator, inhibits tumor metastasis by regulating the HNRNPA2B1/NF-κB pathway in hepatocellular carcinoma.
P2860
Q26739857-3EE21DCB-A795-4171-865C-991E8DFEA9B9Q26766079-8908EAA1-F43D-4BF7-900D-E9DD4EED8DE6Q30234765-86A3DCCE-A73F-4083-87FD-52F7FE9C875AQ33586833-52BB5124-0BD6-4D71-97D9-79538B6298A8Q33648885-50CCB078-9775-42F4-AAAC-EA631DDB7A87Q33702300-735CC4C0-A6E2-41F2-AF7D-776BE2A8891DQ33779972-857CB057-051D-4710-8878-95D4B9D79DA1Q36185753-F95AA041-2C98-4A0D-9AFC-AF7455F6B81FQ36191985-E95B61E0-1000-4AB8-AB81-57216710D94FQ36270963-DF0D55C8-7B3E-44FA-A8A1-83F8680587CDQ37472263-1EC2F3E2-9870-4C1A-8871-FFD8B08B043EQ37520359-7A1B749D-E135-4031-844B-1179925358C8Q37580255-1B90A6C2-549F-4698-BA34-5DD7C646A2E0Q38627909-ECECE2FD-EE0E-415A-8A0B-E1FF38ECDBF9Q38713585-DD0C9950-C922-43C8-95CD-2FBD157FF74DQ38733816-4410E492-6BE6-4F97-B773-356486CE88DEQ38763929-F9E8B841-0B01-4DF2-BD86-7E9A13E59A82Q38823802-A1A32596-94DB-42A5-B0D5-05E27FED1913Q39072215-F0164EC8-3FAC-447B-B158-9DC55C10A805Q39189133-D2A27097-46CF-411B-B0DC-00064ED88FC8Q40786667-B0889207-AAB7-45FB-9161-B828D73CF4FEQ41377011-67032130-7393-4260-9D08-F8089A5939D7Q41700266-0EA6A743-9ABF-4D7E-B408-45BA18DB4C99Q42371270-0C1B9AED-314F-4FB4-8C34-A7DD73B79777Q42516352-145771DE-EFCF-4C0F-B7CD-CBD1DE298630Q44845721-DF64C0AB-39FD-4CEA-98A1-E6758015FAA5Q45419184-E70B39C4-7341-4732-91E2-DD486E1F2A36Q46488114-F61026B0-60C1-4C0F-89ED-4097F7E770C3Q47109133-02CE89DE-462F-4702-ADF9-3EF4D3C7D5DEQ47143083-C222FC57-58DF-48FA-8584-D3A31DAB2615Q47155641-C8F4EE99-5AE5-4814-993E-C7CDD0DF3C4BQ47215507-B6AA726A-5A10-4399-9814-CA27BAFC86E7Q49959240-0DB6DEA0-500F-40D5-9DBD-DE377390F523Q50042578-C38F05F1-AB72-4DFF-B486-BB18E81ABBA2Q50067689-4D69CAED-19F5-4DA3-BFF3-B28F06B40083Q51763083-C358C66F-B5DF-40E0-BB96-6802A761AE17Q52631133-A39106D6-3290-4586-B6CE-A22DDA563EA1Q52935983-7AFF7A2A-D293-4C1F-AD20-A6DADE057092Q53181847-CE594863-9473-4738-ABDD-8C2F55CC6C05Q55073980-68E25310-4979-43F6-B522-F388E362AA3D
P2860
MiR-199a-5p is negatively associated with malignancies and regulates glycolysis and lactate production by targeting hexokinase 2 in liver cancer.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
MiR-199a-5p is negatively asso ...... hexokinase 2 in liver cancer.
@en
MiR-199a-5p is negatively asso ...... hexokinase 2 in liver cancer.
@nl
type
label
MiR-199a-5p is negatively asso ...... hexokinase 2 in liver cancer.
@en
MiR-199a-5p is negatively asso ...... hexokinase 2 in liver cancer.
@nl
prefLabel
MiR-199a-5p is negatively asso ...... hexokinase 2 in liver cancer.
@en
MiR-199a-5p is negatively asso ...... hexokinase 2 in liver cancer.
@nl
P2093
P2860
P356
P1433
P1476
MiR-199a-5p is negatively asso ...... hexokinase 2 in liver cancer.
@en
P2093
Jianren Gu
Qifeng Wang
Shenglin Huang
Taoyang Chen
Weijie Guo
Yingjun Zhao
Zhaoping Qiu
P2860
P304
P356
10.1002/HEP.27929
P407
P50
P577
2015-07-04T00:00:00Z